Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSMTI
āļāļ·āđāļāļāļĢāļīāļĐāļąāļSanara Medtech Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 07, 1994
āļāļĩāļāļĩāđāļMuppalla (Suresh V)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ141
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļApr 07
āļāļĩāđāļāļĒāļđāđ1200 Summit Avenue
āđāļĄāļ·āļāļFORT WORTH
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ76102
āđāļāļĢāļĻāļąāļāļāđ18175292300
āđāļ§āđāļāđāļāļāđhttps://sanaramedtech.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSMTI
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 07, 1994
āļāļĩāļāļĩāđāļMuppalla (Suresh V)
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
Ms. Ann Beal Salamone
Director
Ms. Sara N. Ortwein
Independent Director
Mr. Eric D. Tanzberger
Independent Director
Mr. Eric D. Major
Independent Director
Mr. Keith G. Myers
Independent Director
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
Mr. Jacob A. Waldrop
Chief Operating Officer
Mr. Roszell Mack, III
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
Ms. Ann Beal Salamone
Director
Ms. Sara N. Ortwein
Independent Director
Mr. Eric D. Tanzberger
Independent Director
Mr. Eric D. Major
Independent Director
Texas Capital Texas Small Cap Equity Index ETF
WisdomTree US SmallCap Fund
Goldman Sachs ActiveBeta US Small Cap Equity ETF
ProShares UltraPro Russell2000
Dimensional US Core Equity 1 ETF
Invesco Russell 2000 Dynamic Multifactor ETF
Global X Russell 2000 Covered Call ETF
Global X Russell 2000 ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Texas Capital Texas Small Cap Equity Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.05%
WisdomTree US SmallCap Fund
āļŠāļąāļāļŠāđāļ§āļ0.03%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
ProShares UltraPro Russell2000
Dimensional US Core Equity 1 ETF
Invesco Russell 2000 Dynamic Multifactor ETF
Global X Russell 2000 Covered Call ETF
Global X Russell 2000 ETF
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ